The study by Brun et al [33] evaluated the TIMP-1 immunoreactivity in stroma and in tumour cells in serous and mucinous ovarian tumours and found a tenfold higher TIMP-1 signal in epithelial tumour cells compared to stroma cells. This evidence concerns the gene TIMP1 and ovarian mucinous neoplasm.